Provided by Tiger Trade Technology Pte. Ltd.

Scienture Holdings, Inc.

0.3670
-0.0215-5.53%
Post-market: 0.3662-0.0008-0.22%19:59 EDT
Volume:380.33K
Turnover:138.88K
Market Cap:15.07M
PE:-0.18
High:0.3900
Open:0.3900
Low:0.3532
Close:0.3885
52wk High:2.60
52wk Low:0.2382
Shares:41.06M
Float Shares:33.92M
Volume Ratio:1.36
T/O Rate:1.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0300
EPS(LYR):-2.7049
ROE:-53.47%
ROA:-8.93%
PB:0.24
PE(LYR):-0.14

Loading ...

SCIENTURE Receives U.S. Patent Covering REZENOPY™ (Naloxone HCl) Nasal Spray 10 mg, Strengthening Intellectual Property Protection Through 2041

GlobeNewswire
·
Jun 02

BRIEF-Scienture - Eric Sherb Resigns As CFO Effective May 26, 2026

Reuters
·
May 30

Scienture - Appoints Narasimhan Mani as Interim CFO Effective May 26, 2026 - SEC Filing

THOMSON REUTERS
·
May 30

Scienture names Narasimhan Mani interim CFO after Eric Sherb resigns

Reuters
·
May 30

Scienture Holdings Q1 revenue jumps on Arbli sales, operating expenses steady

Reuters
·
May 18

Scienture Reports First Quarter 2026 Financial Results and Business Update Highlighted by Significant Revenue Growth and Gross Margin Expansion

THOMSON REUTERS
·
May 18

Scienture Holdings, Inc Q1 Gross Profit USD 54 Thousand

THOMSON REUTERS
·
May 18

Scienture Holdings, Inc Q1 Operating Expenses USD 3.56 Million

THOMSON REUTERS
·
May 18

SCIENTURE Reports First Quarter 2026 Financial Results and Business Update Highlighted by Significant Revenue Growth and Gross Margin Expansion

GlobeNewswire
·
May 18

Scienture Holdings Q1 EPS $(0.08) Beats $(0.22) Estimate, Sales $56.325K Up From $10.258K YoY

Benzinga Earnings
·
May 16

Scienture net loss widens 11% to $3.4 million in Q1 FY26

Reuters
·
May 16

Scienture Holdings Inc expected to post a loss of 22 cents a share - Earnings Preview

Reuters
·
May 16

Scienture Holdings Inc expected to post a loss of 22 cents a share - Earnings Preview

Reuters
·
May 09

BRIEF-Scienture Secures $11.0 Million In Non-Dilutive Debt Financing To Accelerate Growth Of Approved Product Portfolio And Advancement Of Research And Development Pipeline

Reuters
·
May 07

Scienture secures $11 million non-dilutive debt financing from institutional investor

Reuters
·
May 07

Scienture Holdings - Enters Definitive Agreement With Summit Biosciences for Exclusive U.S. Rights to Commercialize Rezenopy

THOMSON REUTERS
·
May 07

Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline

GlobeNewswire
·
May 07

Scienture announces third patent granted for Arbli

TIPRANKS
·
May 07

Scienture wins third US patent for ARBLI oral suspension, protection through 2041

Reuters
·
May 06

Scienture Announces Third Patent Grant for Arbli™ (Losartan Potassium) Oral Suspension, Strengthening Long-Term Market Exclusivity Through 2041

THOMSON REUTERS
·
May 06